FDA approves new breast imaging technology

|By:, SA News Editor

The U.S. regulator clears GE Heathcare's (GE) Invenia ABUS, a 3D ultrasound technology that enables clinicians to find ~36% more cancers in women with dense breast tissue. The system can scan in as little as 15 minutes using features that conform to a woman's body providing a more enhanced image.

Approximately 40% of women have dense breast tissue. They have a greater risk of developing breast cancer.